Part D Grant for Coordinated HIV Services and Access to Research for Women, Infants, Children, and Youth Part D Funds Under the Ryan White HIV/AIDS Program, 57805 [2010-23715]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 183 / Wednesday, September 22, 2010 / Notices
oral presentation do not need to register.
Seating is limited and will be on a firstcome, first-served basis.
If you would like to make an oral
presentation during the public session
on November 17, 2010, you must
register and provide an abstract of your
presentation by the close of business on
October 15, 2010. To speak, submit your
name, title, business or organization
affiliation (if applicable), address,
telephone number, fax number, and
email address to Sharon Bakayoko (see
FOR FURTHER INFORMATION CONTACT).
FDA has included areas of interest in
section II of this document. Please
indicate the topic area you wish to
address in your presentation. FDA will
do its best to accommodate requests to
speak. Individuals and organizations
with common interest are urged to
consolidate or coordinate their
presentations and to request time for a
joint presentation. FDA will determine
the amount of time allotted to each
presenter and the approximate time that
each oral presentation is scheduled to
begin. Persons registered to make an
oral presentation should check in at the
registration desk before the workshop.
Time will be allowed during the
scheduled agenda for attendees to ask
questions of panelists. In addition, we
strongly encourage electronic or written
comments to the docket (see section IV
of this document).
If you need special accommodations
because of a disability, please contact
Sharon Bakayoko at least 7 days before
the workshop.
IV. Comments
emcdonald on DSK2BSOYB1PROD with NOTICES
Regardless of attendance at the
workshop, interested persons may
submit to the Division of Dockets
Management (see ADDRESSES) either
electronic or written comments
regarding this document, including
suggestions for workshop topics. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
V. Electronic Access
Information about the Safe Use
Initiative, including the Safe Use
Report, is available on the Internet at
https://www.fda.gov/safeuseinitiative.
Information about the workshop will be
posted on this Web site when it is
available.
VerDate Mar<15>2010
17:32 Sep 21, 2010
Jkt 220001
VI. Transcripts
Please be advised that as soon as a
transcript is available, it will be
accessible at https://www.fda.gov/
safeuseinitiative and https://
www.regulations.gov. It may be viewed
at the Division of Dockets Management
(HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD. A transcript will
also be available in either hardcopy or
on CD–ROM, after submission of a
Freedom of Information request. Written
requests are to be sent to the Division
of Freedom of Information (HFI–35),
Office of Management Programs, Food
and Drug Administration, 5600 Fishers
Lane, rm. 6–30, Rockville, MD 20857.
Dated: September 16, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–23641 Filed 9–21–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Part D Grant for Coordinated HIV
Services and Access to Research for
Women, Infants, Children, and Youth
Part D Funds Under the Ryan White
HIV/AIDS Program
Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of Non-competitive
Award of Part D Funds for the
University of Utah.
AGENCY:
HRSA will be awarding, noncompetitively, Part D Funds to support
family-centered primary medical care,
treatment, and support services (directly
or through contracts) for women,
infants, children, and youth with HIV/
AIDS, to the University of Utah in order
to ensure continuity of critical HIV
medical care and support services, to
women, infants, children and youth in
Salt Lake City, Utah and the
surrounding counties.
SUPPLEMENTARY INFORMATION:
Grantee of record: Utah Department of
Health, Salt Lake City, Utah.
Intended recipient of the award:
University of Utah, Salt Lake City, Utah.
Amount of the award: $350.000 to
ensure continuity of medical care and
support services to the target
population.
SUMMARY:
Project period: August 1, 2010, to July
31, 2011. The period of support for this
award is from August 1, 2010, to July
31, 2011.
Justification for the Exception to
Competition
Funding for critical HIV medical care
and support services to women, infants,
children and youth in Salt Lake City,
Utah and the surrounding areas will be
continued through a non-competitive
award to the University of Utah. The
Utah Department of Health is currently
contracting all of these services to the
University of Utah. The University of
Utah has the clinical, fiscal, and
administrative infrastructure to
administer the Part D Grant since it is
currently the Part C Early Intervention
Services Grant recipient. This is a
temporary replacement award, as the
previous grant recipient serving this
population notified HRSA that it could
not continue as the grantee of record
after July 31, 2010. HRSA’s HIV/AIDS
Bureau identified the University of Utah
as the best qualified entity for this
temporary grant. Since the grant’s
inception, the Utah Department of
Health has contracted with the
University of Utah to provide all Part D
services, and the University can
continue to ensure family-centered care
involving outpatient or ambulatory care
(directly or through contracts) for
women, infants, children, and youth
living with HIV/AIDS. The University is
able to provide critical services with the
least amount of disruption to the service
population while the service area is recompeted.
This supplement will cover the time
period from August 1, 2010, through
July 31, 2011. This service area will be
included in the upcoming competition
for the Part D Coordinated HIV Services
and Access to Research for Women,
Infants, Children, and Youth for project
periods starting August, 2011.
Dora
Ober, by e-mail dober@hrsa.gov, or by
phone, 301–443–0759.
FOR FURTHER INFORMATION CONTACT:
Dated: September 15, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010–23715 Filed 9–21–10; 8:45 am]
BILLING CODE 4165–15–P
Authority: Section 2671 of the Public
Health Service Act, 42 U.S.C. 300ff–71.
CFDA Number: 93.918.
PO 00000
Frm 00070
Fmt 4703
Sfmt 9990
57805
E:\FR\FM\22SEN1.SGM
22SEN1
]]>Agencies
[Federal Register Volume 75, Number 183 (Wednesday, September 22, 2010)]
[Notices]
[Page 57805]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-23715]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Part D Grant for Coordinated HIV Services and Access to Research
for Women, Infants, Children, and Youth Part D Funds Under the Ryan
White HIV/AIDS Program
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice of Non-competitive Award of Part D Funds for the
University of Utah.
-----------------------------------------------------------------------
SUMMARY: HRSA will be awarding, non-competitively, Part D Funds to
support family-centered primary medical care, treatment, and support
services (directly or through contracts) for women, infants, children,
and youth with HIV/AIDS, to the University of Utah in order to ensure
continuity of critical HIV medical care and support services, to women,
infants, children and youth in Salt Lake City, Utah and the surrounding
counties.
SUPPLEMENTARY INFORMATION:
Grantee of record: Utah Department of Health, Salt Lake City, Utah.
Intended recipient of the award: University of Utah, Salt Lake
City, Utah.
Amount of the award: $350.000 to ensure continuity of medical care
and support services to the target population.
Authority: Section 2671 of the Public Health Service Act, 42
U.S.C. 300ff-71.
CFDA Number: 93.918.
Project period: August 1, 2010, to July 31, 2011. The period of
support for this award is from August 1, 2010, to July 31, 2011.
Justification for the Exception to Competition
Funding for critical HIV medical care and support services to
women, infants, children and youth in Salt Lake City, Utah and the
surrounding areas will be continued through a non-competitive award to
the University of Utah. The Utah Department of Health is currently
contracting all of these services to the University of Utah. The
University of Utah has the clinical, fiscal, and administrative
infrastructure to administer the Part D Grant since it is currently the
Part C Early Intervention Services Grant recipient. This is a temporary
replacement award, as the previous grant recipient serving this
population notified HRSA that it could not continue as the grantee of
record after July 31, 2010. HRSA's HIV/AIDS Bureau identified the
University of Utah as the best qualified entity for this temporary
grant. Since the grant's inception, the Utah Department of Health has
contracted with the University of Utah to provide all Part D services,
and the University can continue to ensure family-centered care
involving outpatient or ambulatory care (directly or through contracts)
for women, infants, children, and youth living with HIV/AIDS. The
University is able to provide critical services with the least amount
of disruption to the service population while the service area is re-
competed.
This supplement will cover the time period from August 1, 2010,
through July 31, 2011. This service area will be included in the
upcoming competition for the Part D Coordinated HIV Services and Access
to Research for Women, Infants, Children, and Youth for project periods
starting August, 2011.
FOR FURTHER INFORMATION CONTACT: Dora Ober, by e-mail dober@hrsa.gov,
or by phone, 301-443-0759.
Dated: September 15, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010-23715 Filed 9-21-10; 8:45 am]
BILLING CODE 4165-15-P
